Core Scientific's Q4 revenue missed expectations, causing its shares to decline despite a large net income boost from non-cash holdings.SummarySubscribe to TodayOnChain membership to read full news summaries and browse without display ads.
Unable to recover from roughly $50 million hack, Radiant Capital is winding down
Coinbase Exec Sees Path to Crypto’s ‘Dodd-Frank Moment’ as CLARITY Act Heads for Senate Floor
XRP’s 15-week low puts ETF inflows to the spot-market test
Vitalik Buterin Criticizes AI Nationalism as US Senator Pushes for 50% Stake in OpenAI
Japan’s Ruling Party Pushes Crypto ETFs, Yen-Denominated Stablecoins
TON revives Gram token brand as Telegram CEO Durov says network is ‘returning to roots’
Strategy’s Bitcoin Sale Reshapes Debate Around BTC Treasury Companies
Grayscale sets 0.29% fee for its Hyperliquid ETF, undercutting Bitwise and 21Shares
UK Fintech OpenPayd Eyes $1.1 Billion Nasdaq IPO
Crypto funds suffer second-largest outflows of 2026 while XRP and HYPE attract inflows
